Immunoassay Market 1 14

Empty Capsules Market Worth $4.7 Billion by 2027 – Significant Development, Emerging Growth Factors and Regional Forecast

SHARE THIS ARTICLE

New York: The Report on Empty Capsules Market by Decisive Markets Insights was released in the middle of Covid -19 after a thorough analysis of the top players and primary interviews with key industry figures. A market study from Empty Capsules Market examines the market size, segmentation, future trends, growth rate, drivers and challenges, as well as the sales channels and distributors. The global Empty Capsules market gathered revenue around USD 2.0 Billion in 2020 and market is set to grow USD 4.7 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 7.9% during the prediction period 2021 to 2027.

Overview of Empty Capsules Market Study

Empty Capsules market study conducted by Nova One Advisor is intended at helping stakeholders get a comprehensive overview of potential challenges and undiscovered opportunities. The report offers exclusive insights to help companies and their customers to make informed decision to sustain growth through the assessment period.

Get your Customized Research Report@ https://www.novaoneadvisor.com/report/customization/4319

Growth Factors:

The overall growth of the empty capsules market is largely driven by the growing adoption of capsule formulations among the growing geriatric population, the growth of the pharmaceutical market, increasing R&D activities & clinical trial studies, and advancements in capsule delivery technologies. Emerging markets, with their low manufacturing costs, are expected to present significant opportunities for players. Other areas of opportunity are the development of halal gelatin and vegetarian capsules.

EMPTY CAPSULES: MARKET DYNAMICS
Driver: Increasing demand for nutraceuticals
According to Nova one advisor, The global Empty Capsules market gathered revenue around USD 2.0 Billion in 2020 and market is set to grow USD 4.7 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 7.9% during the prediction period 2021 to 2027.. Nutraceutical products are usually rich in fiber, antioxidants, heart-healthy ingredients, vitamins and minerals, omega-3 fatty acids, vitamin D, calcium, and whole grains.

Over the last few years, the demand for nutraceuticals has been on the rise due to the growing prevalence of non-communicable diseases such as cancer, diabetes, heart ailments, and lung disorders. Also, during the COVID-19 pandemic, personal health has gained prominence in a large part of the global population. This trend has positioned the nutraceutical industry for further expansion and success in the coming years. This is a positive indicator of market growth as most nutraceuticals are marketed in the capsule form.

Opportunity: Expansion of capsule production in emerging countries
The traditionally lucrative pharmaceuticals market is becoming challenging from a growth perspective due to the diminishing drug pipeline, government-induced pressure to reduce costs and regulations on innovative products. This is encouraging pharmaceutical manufacturers to move their manufacturing bases closer to high-growth emerging markets. Through this, manufacturers can take advantage of low-cost manufacturing along with several financial benefits in terms of attractive tax rates and lenient regulatory guidelines for manufacturing.

A number of major pharmaceutical manufacturers are either planning capacity expansions of their existing plants in emerging countries or setting up new manufacturing plants in emerging markets such as China and India. These investments are aiding the growth of pharmaceutical production, in turn, increasing the demand for empty capsules. Some of the recent expansions in this industry include:

In February 2021, Qualicaps Europe S.A.U expanded its presence in the South Asia region. In addition to two production sites based in Europe, the company has capsule manufacturing experts located in the EMEA and South Asia.
In October 2020, Lonza invested USD 93 million (CHF 85 million) in its Capsules and Health Ingredients (CHI) Division, a dosage form delivery partner to the biopharma and health nutrition industry. The investment has been made to expand its overall production capacity of capsules within CHI’s Capsugel portfolio by 30 billion capsules annually while maintaining the high-quality standards with Lonza’s Sigma Series. The investment is expected to increase its capsule production capacity by 15.0%. Lonza’s newest investment will be released to eight sites, including Bornem, Belgium; Colmar, France; Greenwood, South Carolina; Haryana, India; Jakarta, Indonesia; Puebla, Mexico; Sagamihara, Japan; and Suzhou, China.
Challenges: Rising prices and lower availability of raw materials in the gelatin industry
Globally, the demand for gelatin and its raw materials has witnessed a significant increase over the entire application spectrum—the pharmaceutical industry, in which the demand for capsules for pharmaceutical production has registered a vast increase, and the food processing, nutraceutical, leather, cosmetic, dying & tanning, and paper production industries. The use of gelatin in food preparations has increased six-fold in the last decade. Similar trends have been observed in the nutraceutical and cosmetic industry, where gelatin is used for the production of dietary supplement capsules, lotions, shampoos, hair sprays, and creams. On the other hand, the leather, tanning, and paper production industries use pigskin and bovine skin for the production of various commercial goods.

The increase in demand has boosted the prices of these ingredients. In the last five years, the gelatin manufacturing industry has faced challenges due to the lower availability of raw materials—bovine hide and bones and pigskin. Raw material costs constitute almost 50–55% of the total costs in the gelatin industry. According to a report by Nitta Gelatin (India), the gelatin industry consumes around 18,000 tons of crushed bones per month in India. However, availability came down to 15,000 tons in the earlier months of 2017. The annual gelatin production is expected to come down to 15,000 tons from 20,000 tons in 2018, due to the non-availability of bones owing to the ban imposed by the government on the slaughter of cattle.

The outbreak of bovine and swine diseases has resulted in regulatory restrictions and guidelines for bovine and pig farmers, which has increased the cost of farming. Feed prices have also increased. The cumulative effect of these factors and the subsequent price hikes have been passed onto end users such as gelatin manufacturers and thus have increased the overall gelatin prices. The slow declining availability of raw material is, therefore, intensifying the demand for these ingredients in the pharmaceutical industry, thus creating a supply-demand imbalance. Thus, raw material supply has to be considered carefully to meet the demand for raw material and gelatin across all industries.

Buy Complete Assessment of Empty Capsules market Now@ https://www.novaoneadvisor.com/report/checkout/4319

COVID-19 Impact on Empty Capsules Sales

Businesses today are operating in a dynamic environment. Earlier focus primarily concentrated on keeping pace with changing consumer preferences. COVID-19 outbreak was unprecedented and exposed vulnerabilities of various industries. Pandemic-induces obstacles also were registered in the Empty Capsules market.

Sales plummeted as COVID-19 gradually tightened its noose worldwide. Supply-chain disruptions caused massive losses, while demand took nose-dive as consumers remained indoors with affected countries implementing either partial or complete lockdown.

Gradual recovery however is on the cards with the roll out of vaccinations. Nonetheless, consecutive waves of the virus compelled businesses to stay prepared for the worst. As government and healthcare organizations successfully implement steps to contain the spread of COVID-19, industries have begun operations, albeit at a slow and more cautious pace.

Against this backdrop, Nova one advisor’s study predicts gradual recovery for the Empty Capsules market 2021 onwards. This trend will however continue through the course of the report’s assessment period

Key Players:

This report provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the Empty Capsules market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.

Some of the prominent players in the Empty Capsules market include:

Capsugel (US), ACG Worldwide (India), Qualicaps (US), Suheung Co. Ltd. (Korea), CapsCanada Corporation (Canada), Qingdao Yiqing Medicinal Capsules Co., Ltd. (China), Shanxi Guangsheng Medicinal Capsules Co., Ltd. (China), Healthcaps India Ltd. (India) and among others

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

By Type

  • Gelatin Capsules
    • Porcine
    • Bovine
    • Bone Meal
    • Other Gelatin Sources
  • Non-Gelatin Capsules
    • Hydroxypropyl Methylcellulose (HPMC)
    • Pullulan and Starch Material

By Functionality

  • Immediate-release Capsules
  • Sustained-release Capsules
  • Delayed-release Capsules

By Application

  • Antibiotic & Antibacterial Drugs
  • Dietary Supplements
  • Antacid & Antiflatulent Preparations
  • Antianemic Preparations
  • Anti-inflammatory Drugs
  • Cardiovascular Therapy Drugs
  • Cough & Cold Drug Preparations
  • Other Therapeutic Applications

By End User

  • Pharmaceutical Industry
  • Nutraceutical Industry
  • Cosmetic Industry
  • Research Laboratories

Why Buy this Report?

The purpose of Nova one advisor’s Empty Capsules market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

Download This Full Research Report, Click Here@ https://www.novaoneadvisor.com/report/checkout/4319

About Us

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@novaoneadvisor.com

Web: https://www.novaoneadvisor.com/

James Root

James Root have over 6+ years of experience working in business development, and customer retention. I’ve gained my experience through serving higher education, healthcare, automotive, aerospace, manufacturing, local government and hospitality businesses with technical solutions.

View all posts by James Root →

Leave a Reply

Your email address will not be published.